Related Experiment Video
Updated: Jun 4, 2026

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
Published on: April 23, 2021
miR-29b regulates migration of human breast cancer cells
1School of Life Science, NJU 3 M Laboratory, Jiangsu Diabetes Research Center, Nanjing, Jiangsu, China. wangchen922@sina.com
Abstract:
microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by targeting mRNAs, inhibiting the expression of the associated proteins. Although a role for aberrant miRNA expression in cancer has been postulated, the pathophysiologic role and relevance of aberrantly expressed miRNAs in tumor biology has not been established. We evaluated the expression pattern of miRNAs in human breast cancer cells by qPCR, finding out an up-regulated miRNA miR-29b and studying its biological effect by migration assay. We defined a target gene PTEN by bioinformatics approach and western blot. In breast cancer cell line MDA-MB-231 cell, which migrate faster than MCF-7, we observed that miR-29b was highly over-expressed. Inhibition of miR-29b in cultured cells increased the expression of the phosphatase and tensin homolog (PTEN) tumor suppressor, promoting apoptosis, decreasing migration, and decreasing invasion. In contrast, enhanced miR-29b expression by transfection with pre-miR-29b decreased the expression of PTEN and impaired apoptosis, increasing tumor cell migration and invasion. Moreover, PTEN was shown to be a direct target of miR-29b and was also shown to contribute to the miR-29b-mediated effects on cell invasion. Modulation of miR-29b altered the role of PTEN involved in cell migration and invasion. Aberrant expression of miR-29b, which modulates PTEN expression, can contribute to migration, invasion, and anti-apoptosis.
Insights
MicroRNAs (miRNAs) regulate gene expression. This study found that the over-expressed miR-29b in breast cancer cells targets PTEN, promoting tumor cell migration and invasion while inhibiting apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression.
- Aberrant miRNA expression is implicated in cancer, but their specific roles are not fully understood.
- Understanding miRNA roles is crucial for cancer biology and therapeutic development.
Purpose of the Study:
- To investigate the role of aberrantly expressed miRNAs in human breast cancer.
- To identify specific miRNAs and their targets involved in tumor progression.
- To elucidate the functional impact of miR-29b on breast cancer cell behavior.
Main Methods:
- Quantitative PCR (qPCR) to assess miRNA expression levels.
- Bioinformatics and Western blot to identify and validate miRNA targets.
- Cell migration assays and apoptosis studies to evaluate functional effects.
Main Results:
- miR-29b was found to be significantly up-regulated in aggressive breast cancer cells (MDA-MB-231).
- miR-29b directly targets and down-regulates the tumor suppressor PTEN.
- Inhibition of miR-29b increased PTEN, promoted apoptosis, and reduced migration/invasion; conversely, increased miR-29b decreased PTEN and enhanced these aggressive phenotypes.
Conclusions:
- Aberrant expression of miR-29b contributes to breast cancer progression by modulating PTEN.
- miR-29b promotes tumor cell migration, invasion, and resistance to apoptosis.
- Targeting miR-29b may represent a novel therapeutic strategy for breast cancer.
Related Concept Videos
Cell Migration
Chemotaxis and Direction of Cell Migration

